New drug class may help alleviate IBS symptoms by targeting the central nervous system

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

Irritable bowel syndrome (IBS) is a common digestive disorder that affects the intestine, causing symptoms such as abdominal pain, bloating, gas, and changes in bowel habits, including diarrhea, constipation, or both.